Hancock Jaffe Laboratories Inc Акции в обращении
Что обозначает Акции в обращении в Hancock Jaffe Laboratories Inc?
Акции в обращении Hancock Jaffe Laboratories Inc является 8.685M
Какое определение для Акции в обращении?
Акции в обращении - это все акции корпорации или финансового актива, которые были разрешены, выпущены и приобретены инвесторами и находятся в их собственности.
Shares outstanding includes all stock held by investors including both common shares held by the public and restricted shares owned by the company's internal managements. Shares outstanding have rights and represent an ownership in the corporation by the person who holds the shares. They are distinguished from treasury shares, which are shares held by the corporation itself and have no exercisable rights. Shares outstanding plus treasury shares together amount to the number of issued shares.
Shares outstanding can be calculated as either basic or fully diluted. The basic count is the current number of shares. Dividend distributions and voting in the general meeting of shareholders are calculated according to this number. The fully diluted shares outstanding count, on the other hand, includes diluting securities, such as warrants, capital notes or convertibles. If the company has any diluting securities, this indicates the potential future increased number of shares outstanding. A company's market capitalization is calculated by multiplying the price of one of its shares by the total number outstanding shares a company has issued.
Акции в обращении компаний в Health Care сектор на NASDAQ по сравнению с Hancock Jaffe Laboratories Inc
Что делает Hancock Jaffe Laboratories Inc?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Компании с акции в обращении похож на Hancock Jaffe Laboratories Inc
- Logic Instrument S.A имеет Акции в обращении из 8.647M
- Sportscene имеет Акции в обращении из 8.648M
- Exicure Inc имеет Акции в обращении из 8.651M
- Athenex Inc имеет Акции в обращении из 8.663M
- First Internet Bancorp имеет Акции в обращении из 8.668M
- Northern Lion Gold имеет Акции в обращении из 8.683M
- Hancock Jaffe Laboratories Inc имеет Акции в обращении из 8.685M
- Wereldhave Belgium SCA имеет Акции в обращении из 8.692M
- Gravitas One Capital имеет Акции в обращении из 8.700M
- OFS Credit имеет Акции в обращении из 8.700M
- CoreCard имеет Акции в обращении из 8.701M
- MoSys имеет Акции в обращении из 8.705M
- Kura Sushi USA имеет Акции в обращении из 8.711M